Physician profile
Mark E Lund
NPI 1952330300
$1,261.27
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $199 · 2022: $519 · 2023: $501 · 2024: $42.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $543.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $543.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $389.84 | 2021-2023 | Trelegy Ellipta, Arexvy, Nucala |
| Astrazeneca Pharmaceuticals LP | $267.97 | 2021-2023 | Fasenra, Breztri |
| Mallinckrodt Hospital Products INC. | $267.89 | 2021-2023 | Acthar |
| Insmed, INC. | $160.86 | 2023-2024 | Arikayce |
| Amgen INC. | $91.30 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.99 | 2021 | |
| Baxter Healthcare | $24.95 | 2023 | Hillrom - Life 2000 Ventilation System |
| Merck Sharp & Dohme LLC | $18.30 | 2023 | Zerbaxa, Recarbrio |
| Mylan Specialty L.P. | $15.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Lund listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.